Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre
Background. The incidence of nonalcoholic fatty liver disease (NAFLD) continues to parallel the rise in obesity rates. Endobariatric devices such as the intragastric balloon (IGB) may provide an alternative treatment option. Methods. Outcomes following IGB treatment in 135 patients with obesity and...
Main Authors: | Vi Nguyen, Jiawei Li, Jaslyn Gan, Paul Cordero, Shuvra Ray, Alessandro Solis-Cuevas, Mai Khatib, Jude A. Oben |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2017/4697194 |
Similar Items
-
Intragastric Balloon Rupture
by: George Lim, et al.
Published: (2014-11-01) -
ORBERATM INTRAGASTRIC BALLOON SYSTEM
by: Issam Merdan
Published: (2015-12-01) -
Intragastric balloon and multidisciplinary team
by: R. A. Mazure, et al. -
Endoscopy-guided intragastric balloon
by: Siddharth Mohanlal Jain, et al.
Published: (2020-01-01) -
Intragastric balloon therapy for obesity: Is it safe and effective?
by: Onur Bayraktar, et al.
Published: (2019-03-01)